Betacetylmethadol
From Wikipedia, the free encyclopedia
Systematic (IUPAC) name | |
---|---|
(3S,6R)-6-(dimethylamino)-4,4-diphenyl-3-heptanyl acetate | |
Clinical data | |
Legal status | Prohibited (S9) (AU) Schedule I (US) |
Identifiers | |
CAS number | 17199-59-6 |
ATC code | None |
PubChem | CID 62710 |
DrugBank | DB01522 |
ChemSpider | 56457 |
Chemical data | |
Formula | C23H31NO2 |
Mol. mass | 353.498 g/mol |
SMILES
| |
| |
Betacetylmethadol is a synthetic opioid.[1] It is a diastereoisomer of alphacetylmethadol (as well as levacetylmethadol).[1] In the United States, betacetylmethadol is a Schedule I drug under the Controlled Substances Act.[2]
See also
References
- ↑ 1.0 1.1 Newman JL, Vann RE, May EL, Beardsley PM (October 2002). "Heroin discriminative stimulus effects of methadone, LAAM and other isomers of acetylmethadol in rats". Psychopharmacology 164 (1): 108–14. doi:10.1007/s00213-002-1198-8. PMID 12373424.
- ↑
|
This article is issued from Wikipedia. The text is available under the Creative Commons Attribution/Share Alike; additional terms may apply for the media files.